Key facts
- This page summarizes Melissa B. Epperly's Form 4 filing for Roivant Sciences Ltd. (ROIV).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 27 Jan 2025, 21:00.
Melissa B. Epperly - 23 Jan 2025 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)
- Reporting relationship
- Director
- Issuer ticker
- ROIV
- Reported as of
- 23 Jan 2025
- Net transaction value
- -$2,018
- SEC form
- 4
- Accepted by SEC
- 27 Jan 2025, 21:00:29 UTC
- Prior SEC filing
- 23 Oct 2024
- Next SEC filing
- 21 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Jo Chen, as Attorney-in-Fact for Melissa B. Epperly
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Melissa B. Epperly filed Form 4 for Roivant Sciences Ltd. (ROIV) on 27 Jan 2025.
Change
- Previous filing in this sequence was filed on 23 Oct 2024.
- Current net transaction value: -$2,018.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ROIV
transaction
Common Shares
Award
- Transaction value
- $0
- Shares
- +1,672
- Change %
- +4.4%
- Price
- $0.000000
- Shares after
- 39,709
- Date
- 23 Jan 2025
- Ownership
- Direct
- Footnotes
- F1
ROIV
transaction
Common Shares
Tax liability
- Transaction value
- $2,018
- Shares
- -180
- Change %
- -0.45%
- Price
- $11.21
- Shares after
- 39,529
- Date
- 23 Jan 2025
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.
Footnote F2
Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares.